Business Context and Reporting Period
Company: Callan JMB Inc. (CJMB)
Filing Type: Form 8-K (Current Report)
Date of Report: May 26, 2026
Principal Office: Spring Branch, Texas
Listing: Nasdaq Capital Market (Common Stock, $0.001 par value)
Key Financial Metrics and Transaction Details
This filing reports the entry into a material definitive agreement rather than periodic financial results. Key transaction metrics include:
- Offering Size: Up to $5,000,000 aggregate offering price of Common Stock.
- Sales Agent: Alexander Capital, L.P.
- Commission: 3.0% of gross proceeds from each sale.
- Expense Reimbursement: Up to $50,000 for initial legal fees and up to $3,000 quarterly thereafter.
- Use of Proceeds: Working capital and general corporate purposes.
Note: The filing text does not provide current revenue, profit, cash flow, margins, debt, or liquidity figures.
Material Changes and Strategic Actions
The primary material change is the execution of an At-The-Market (ATM) Issuance Sales Agreement on May 26, 2026. This agreement allows the Company to sell shares from time to time through Alexander Capital in "at the market offerings" on the Nasdaq Capital Market or other trading venues. The Company has filed a registration statement on Form S-3 (File No. 333-296253) to facilitate this offering.
Outlook, Risks, and Management Commentary
Compliance Status: The filing contains forward-looking statements regarding the Company's intent to submit a plan to regain compliance with the Nasdaq Stockholders' Equity Requirement within 45 calendar days and its ability to meet the Nasdaq-imposed deadline.
Risks and Uncertainties: Management highlights several risks that could cause actual results to differ from projections, including:
- General economic, financial, and business conditions.
- Ability to successfully implement strategic initiatives.
- Supply chain disruptions.
- Regulatory compliance and legal proceedings.
- Uncertainty regarding the successful sale of shares under the ATM agreement.
Investor Verification Checklist
- Verify the Company's current stockholders' equity balance to assess the severity of the Nasdaq compliance issue.
- Review the full text of the At-The-Market Issuance Sales Agreement (Exhibit 10.1) for termination rights and specific covenants.
- Monitor the Company's progress in submitting the compliance plan to Nasdaq within the 45-day window.
- Check subsequent filings for actual share sales and proceeds generated under the new ATM facility.
- Review the most recent Form 10-K and 10-Q for detailed financial position data not included in this 8-K.